Pharmaceutical Multidistrict Litigation Attorneys
When prescription drugs cause widespread harm, individual lawsuits are rarely enough. Stag Liuzza represents clients nationwide in large-scale pharmaceutical multidistrict litigation, holding drug manufacturers accountable for dangerous products, undisclosed risks, and corporate misconduct. Our focus is on complex cases where science, evidence, and national coordination matter.
Holding Drug Manufacturers Accountable on a National Scale
Pharmaceutical litigation often involves widespread harm caused by drugs that were improperly tested, aggressively marketed, or released without adequate safety warnings. These cases are rarely isolated. When a prescription drug injures thousands of patients across the country, the litigation is typically consolidated into multidistrict litigation (MDL) in federal court.
Stag Liuzza has extensive experience handling complex, high-stakes litigation involving pharmaceutical misconduct, toxic exposure, and corporate failures to disclose known risks. Our firm represents individuals harmed by dangerous drugs while working alongside national leadership counsel in large-scale MDL proceedings.
PHARMACEUTICAL cases
Our accomplished attorneys have successfully litigated thousands of drug and medical device lawsuits nationwide. We provide our clients with the attention and respect they deserve.
What Is Pharmaceutical Multidistrict Litigation?
Multidistrict litigation is a federal process that consolidates similar lawsuits from across the United States into a single court for coordinated discovery and pretrial proceedings. MDLs are commonly used in pharmaceutical cases where:
-
A drug causes similar injuries to many people
-
Scientific and medical evidence overlaps across cases
-
Centralized discovery promotes efficiency and consistency
Pharmaceutical MDLs allow courts to evaluate complex evidence, corporate conduct, and regulatory failures in a structured way. Individual cases remain separate, but key issues are addressed collectively.
Types of Pharmaceutical Cases We Handle
Stag Liuzza focuses on large-scale pharmaceutical litigation, not isolated medical malpractice claims. Our work centers on cases involving systemic drug safety failures, including:
Dangerous and Defective Drugs
Drugs that cause serious injury because of design defects, inadequate testing, or undisclosed risks.
Failure to Warn
Cases where manufacturers failed to properly warn doctors and patients about known or foreseeable dangers.
Off-Label Promotion
Illegal marketing of drugs for uses not approved by the FDA, often without adequate safety data.
Hormone-Based and Long-Term Exposure Drugs
Medications that expose patients to prolonged hormone disruption or cumulative toxicity over time.
Emerging Mass Tort Investigations
Potential nationwide claims involving drugs currently under scientific or regulatory scrutiny.
Current and Recent Pharmaceutical MDL Focus Areas
Our firm is actively involved in pharmaceutical litigation involving drugs that have affected patients nationwide, including:
Depo-Provera lawsuits involving alleged links to brain tumors and long-term health risks
Defective drugs and medical devices associated with serious injuries
Investigations into pharmaceutical companies accused of withholding safety data or misleading the public
These cases often involve years of internal corporate knowledge, complex medical causation, and extensive discovery.
Why Pharmaceutical MDLs Matter
Large pharmaceutical settlements rarely happen by accident. Many of the largest drug settlements in U.S. history involved manufacturers that:
- Promoted drugs for unapproved uses
- Failed to report adverse safety data to regulators
- Prioritized profits over patient safety
Multidistrict litigation plays a critical role in uncovering internal documents, corporate decision-making, and the full scope of patient harm. For injured individuals, these cases offer a pathway to accountability when harm occurs on a national scale.
Our Approach to Pharmaceutical Litigation
Stag Liuzza approaches pharmaceutical multidistrict litigation with the understanding that these cases are won through preparation, science, and persistence.
We work closely with:
Medical experts
Epidemiologists and toxicologists
National MDL leadership teams
Our attorneys are experienced in evaluating complex medical records, understanding scientific causation, and presenting evidence in cases involving widespread harm.
National Reach, Trial-Focused Experience
Although based in Louisiana, Stag Liuzza’s pharmaceutical litigation practice is national in scope. Our attorneys regularly handle cases involving clients from across the United States and participate in federal MDL proceedings.
We are known for:
- Taking on complex, document-intensive cases
- Representing clients in litigation involving powerful corporate defendants
- Maintaining a trial-ready approach even in large consolidated proceedings
Who May Have a Pharmaceutical MDL Claim?
You may have a potential claim if:
-
You were prescribed a drug later linked to serious injury
-
You developed unexpected or unexplained health conditions after prolonged use
-
You were never warned about known risks associated with the medication
-
Scientific research or litigation has identified patterns of harm
Each case is evaluated individually, even when part of a larger MDL.
Why Choose Stag Liuzza as Your Pharmaceutical MDL Attorneys?
Stag Liuzza handles pharmaceutical MDL cases with a focus on complex science, national coordination, and corporate accountability. We work alongside MDL leadership and medical experts to pursue high-impact litigation against drug manufacturers when widespread harm occurs.
Speak With Our Pharmaceutical Multidistrict Litigation Team
If you believe a prescription drug caused serious harm, the next step is understanding whether your case may be part of a larger pharmaceutical MDL. Stag Liuzza reviews potential claims nationwide and evaluates whether injuries align with ongoing or emerging litigation. Speaking with an experienced pharmaceutical litigation team can help you understand your options and whether action is warranted.
OUR team
We take the bull by the horns and give you clear and practical advice. Personal, to the point, and in plain language. Any questions? Feel free to call or to drop by.
$1.056 billion verdict against Exxon Mobil
Stag Liuzza fights industry giants across the country and holds them accountable for their actions. We strive to ensure that communities have access to safe drinking water, clean air, and a healthy environment.
-
One Canal Place
365 Canal Street Suite 2850 New Orleans, LA 70130 - 504-593-9600
stagliuzza.com is operated and provided by Stag Liuzza, LLC responsible attorneys Michael G. Stag and Ashley M. Liuzza. Stag Liuzza, LLC is officed in New Orleans, LA, and our attorneys are licensed in Louisiana and Mississippi.
Nothing on this site should be taken to establish an attorney-client relationship with us unless and until a contract for representation is signed. The attorneys of Stag Liuzza are licensed in Louisiana and Mississippi and may associate counsel licensed in other jurisdictions as necessary.
Past results do not guarantee any similar result or outcome in your claim. Each claim is different.